Janney Montgomery Scott Downgrades Agile Therapeutics (AGRX) to Neutral (Friday)

December 26, 2017 5:26 AM EST Send to a Friend
Janney Montgomery Scott downgraded Agile Therapeutics (NASDAQ: AGRX) from Buy to Neutral with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login